CFF Logo - click for home page
Sign up to receive updates from the Cystic Fibrosis Foundation.
ABOUT CYSTIC FIBROSIS ABOUT THE CYSTIC FIBROSIS FOUNDATION LIVING WITH CYSTIC FIBROSIS TREATMENTS RESEARCH OVERVIEW GET INVOLVED!
Search
Quick Links
Login
Find A Chapter
Great Strides
Volunteer
Employment Opportunities
Advocate
Find A Clinical Trial
Care Center Network
Drug Development Pipeline
CF Services Pharmacy
Make a Donation
Visit the Cystic Fibrosis Services Pharmacy
Sign Up to Volunteer for the Cystic Fibrosis Foundation
Donate to the Cystic Fibrosis Foundation
Home  >   ABOUT THE CYSTIC FIBROSIS FOUNDATION  >   Press Room  >   2006 Press Releases
Display a Printer Friendly Version This Page

2006 Press Releases

 
12/20/06   CF Foundation Publicly Reports Care Center Data for National Care Center Network
11/02/06   Denver to Host Largest Gathering of Cystic Fibrosis Scientists and Clinicians in the World
11/02/06   Cystic Fibrosis Foundation Launches New Web Site
07/13/06   CFFT Awards Milestone Payment to Predix for Drug Discovery Progress
06/01/06   Foundation and CombinatoRx Collaborate to Develop Novel Therapeutics for Cystic Fibrosis
05/31/06   U.S. Congress Recognizes National Awareness Month
05/17/06   Compound Known as VX-770 Begins Clinical Trials
04/05/06   FDA Grants SLIT Amikacin Orphan Drug Designation; Clinical Trials Planned
04/05/06   CF Foundation Takes GREAT STRIDES for Cystic Fibrosis
03/23/06   CF Foundation Commits $13 Million More to Vertex
02/14/06   Copernicus to Further Develop Non-Viral Gene Therapy for Cystic Fibrosis With Continued Support from Cystic Fibrosis Foundation Therapeutics
02/07/06   Yasoo Health to Develop First-of-Its Kind Multi-vitamin for CF
01/30/06   Inspire Announces FDA Go-Ahead for Phase 3 Trial on INS37217 (denufosol)
01/18/06   Saltwater Solution Offers Novel Therapy for Cystic Fibrosis Patients
01/18/06   Researchers find effective, cheap treatment for cystic fibrosis lung disease
01/12/06   Vertex and Foundation Announce New Agreement
12/06/05   PTC Therapeutics, Inc. Research Study Advances to Phase II
PTC124 is an orally administered drug targeting nonsense mutations and is being studied as a potential treatment for CF.
03/16/05   Cystic Fibrosis Foundation Therapeutics and Alnylam Initiate Collaboration to Discover RNAi Therapeutic to Treat CF -- CFFT to Provide $1.5 Million
Message from the President
News & Events
Press Room
>  2008 Press Releases
>  2007 Press Releases
>  2006 Press Releases
>  CFF In the News
About 65 Roses
Locations
Milestones Campaign
Publications & Videos
Employment Opportunities
Contact Us
Sign Up for GREAT STRIDES, the Cystic Fibrosis Foundation fundraising walk Shop for gifts to benefit the Cystic Fibrosis Foundation
Make a Donation  |  Update Your Profile  |  Site Map  |  Contact Us  |  Privacy Policy  |  Legal Terms & Conditions